$6.7MSeed, 5 November 2025
Funds dataset expansion, platform scaling, regulatory milestones and commercialization of its MASH assay.
- Amount
- $6.7M
- Stage
- Seed
- Announced
- 5 November 2025
- Lead
- Felicis Ventures
- Other investors
- Illumina Ventures, SeaX Ventures, Alumni Ventures, AME Cloud Ventures
- Use of funds
- Funds dataset expansion, platform scaling, regulatory milestones and commercialization of its MASH assay.
- Checked
- Matched to an official SEC filing
- Sources
- Hepta: $6.7 Million Seed Funding Closed To Advance Liquid Biopsy-Based AI Diagnostics For Chronic Liver Diseas businesswire.com
Hepta: $6.7 Million Seed Funding Closed To Advance Liquid Biopsy-Based AI Diagnostics For Chronic Liver Diseas news.google.com